Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Ingelheim Corp.

Division of Boehringer Ingelheim International GmbH
us.boehringer-ingelheim.com

Latest From Boehringer Ingelheim Corp.

Strong Xarelto Label Warnings Lead To Another Jury Win For Bayer And Janssen

Philadelphia jurors find that warnings of bleeding risk with Xarelto are adequate, giving companies 5-0 litigation score; sixth trial in June.
Legal Issues Drug Safety

Xarelto Liability Suit: Is Label 'Silent' About Increased Bleeding Risk?

Even after multiple bellweather wins, Janssen and Bayer still face claims they did not warn doctors about concomitant use with Plavix and aspirin; as case begins in Philadelphia, plaintiff's attorney tells jury the firms were 'silent,' while defense points to doctors' testimony that a different warning would not have changed their prescribing.
Drug Safety Legal Issues

Product Liability Litigation: 'Stand And Fight' Strategy Pays Off For Drug And Device Makers

Legal analytics company Lex Machina finds that manufacturers most often win at summary judgement stage; however, about 96% of cases settle or are resolved procedurally.

BioPharmaceutical Policy

Asia Executives To Watch: Gilead, BMS, AZ In Japan, WuXi NextCode

Multinational drug makers continue shuffling their senior management in Asia as Gilead Sciences has a new president for Japan, and so does Bristol-Myers Squibb. WuXi NextCode hires a new chief digital officer.

Appointments Asia Pacific
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register